WPI 2345 (Lacosamide 200 mg)
Pill with imprint WPI 2345 is Blue, Elliptical / Oval and has been identified as Lacosamide 200 mg. It is supplied by Actavis Pharma, Inc..
Lacosamide is used in the treatment of seizures and belongs to the drug class miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Lacosamide 200 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 2345
Lacosamide
- Imprint:
- WPI 2345
- Strength:
- 200 mg
- Color:
- Blue
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-2345
More about lacosamide
- Lacosamide Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 102 Reviews
- Drug class: miscellaneous anticonvulsants
Consumer resources
- Lacosamide oral/injection
- Lacosamide Injection
- Lacosamide Oral Solution
- Lacosamide Tablets
- Lacosamide (Advanced Reading)
- Lacosamide Intravenous (Advanced Reading)
Other brands: Vimpat
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
